Lactated Ringers Injection Market to reach USD 2.9 Bn by 2036, driven by rising hospital admissions, increasing surgical ...
Understanding the benefits of matrix converters for EV chargers and a comparison of different matrix converter topologies.
The FDA has authorized urcosimod 0.05% for single-patient expanded access, or compassionate use, in a patient with neuropathic corneal pain, according to a press release from Okyo.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results